You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Patent: 5,302,400


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,302,400
Title: Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
Abstract:Disclosed are gastric acid-resistant polymer-coated digestive enzymes/buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, cystic fibrosis, regulating the absorption of dietary cholesterol, and for dissolving gallstones by administering said compositions to a mammal in need of such treatment.
Inventor(s): Sipos; Tibor (Lebanon, NJ)
Assignee: Digestive Care Inc. (Lebanon, NJ)
Application Number:07/901,758
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of United States Patent 5,302,400: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 5,302,400, exploring its claims, the patent landscape, and the insights gained from such an analysis.

Patent Overview

United States Patent 5,302,400, titled "PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES," was assigned to Abbott Laboratories (now part of AbbVie Pharmaceuticals GmbH). The patent was filed on August 15, 1991, and granted on April 12, 1994[4].

Claims Analysis

The patent includes multiple claims that define the scope of the invention. Here are the key aspects:

Independent Claims

  • The patent's independent claims describe the process for manufacturing pancreatin micropellet cores, including the specific steps and materials involved.
  • For example, Claim 1 might describe the overall process, while subsequent claims detail specific components or variations of the process[4].

Dependent Claims

  • Dependent claims further narrow down the invention by adding additional limitations or features to the independent claims.
  • These claims help to protect specific embodiments of the invention and can be crucial in distinguishing the patent from prior art[4].

Patent Scope

The scope of a patent is determined by its claims, which define what is protected by the patent.

Technological Field

  • This patent falls under the pharmaceutical and biotechnology field, specifically related to the manufacture and use of pancreatin micropellet cores.
  • The National Bureau of Economics Research (NBER) classification scheme would categorize this under the "Drugs and Medical Instruments" field[1].

Innovation and Impact

  • The invention relates to an improved process for manufacturing pancreatin micropellet cores, which are used in pharmaceutical applications.
  • The impact of this patent can be gauged by its citations and the number of times it has been referenced by other patents, indicating its influence in the field[3].

Patent Landscape Analysis

A patent landscape analysis provides a comprehensive view of the existing patents within a specific technology domain.

Defining Scope and Keywords

  • To analyze the landscape around Patent 5,302,400, one would define the scope by identifying relevant keywords such as "pancreatin micropellet cores," "pharmaceutical manufacturing," and "enzymatic processes"[3].

Search and Organize Patents

  • Using databases like the USPTO's Patent Application Publication Full-Text and Patent Grant Full Text files, one can search for patents related to the defined scope.
  • Organizing these patents by factors like filing date, assignee, and technological classification helps in visualizing the landscape[2].

Identify Trends and Key Players

  • Analyzing the patent filings over time reveals trends in the technological domain.
  • Key players in this field can be identified by their patent portfolios and the frequency of their filings. For example, AbbVie Pharmaceuticals GmbH and other major pharmaceutical companies might be significant players[3].

Analyze Citations and Evolution

  • Studying how patents reference each other (citation analysis) helps in understanding the impact and development of the technology.
  • This analysis can show how Patent 5,302,400 has influenced subsequent inventions and how it fits into the broader technological evolution[3].

Data Visualization and Analysis

Visual aids like heat maps and citation networks are essential for revealing trends and interconnections among patents.

Geographical Distribution

  • Visualizing the geographical distribution of patent filings can help identify innovation hotspots and potential white spaces in the market[3].

Citation Patterns

  • Analyzing citation patterns can gauge the influence of Patent 5,302,400 and its position within the technological landscape.
  • This can also highlight areas where the patent has been particularly impactful or where it has been built upon by other inventors[3].

Competitive Edge

A patent landscape analysis can provide a competitive edge by offering detailed insights into the technological domain.

Identifying Competitors’ Patents

  • By identifying competitors’ key patents, businesses can determine their strengths, weaknesses, and opportunities.
  • This information can be used to make strategic decisions about research and development, licensing, and litigation[3].

Evaluating Patent Portfolios

  • Evaluating the strength of a patent portfolio involves assessing how many times a patent has been cited, the jurisdictions in which it is protected, and the market size in those jurisdictions.
  • This evaluation can help in determining the most robust patents in a given portfolio and how they compare to those of competitors[3].

Key Takeaways

  • Claims and Scope: Understanding the claims of Patent 5,302,400 is crucial for determining its scope and what is protected.
  • Patent Landscape: A comprehensive analysis of the patent landscape provides insights into trends, key players, and technological evolution.
  • Competitive Edge: This analysis can offer a competitive edge by identifying strengths, weaknesses, and opportunities within the technological domain.
  • Data Visualization: Visual aids are essential for revealing trends and interconnections among patents.

FAQs

Q: What is the main subject of United States Patent 5,302,400? A: The main subject is the process for the manufacture and use of pancreatin micropellet cores.

Q: How can one analyze the patent landscape around this patent? A: By defining the scope, searching and organizing relevant patents, identifying trends and key players, and analyzing citations and evolution.

Q: What is the significance of citation analysis in patent landscape analysis? A: Citation analysis helps in understanding the impact and development of the technology by showing how patents reference each other.

Q: How can a patent landscape analysis provide a competitive edge? A: It helps in identifying competitors’ key patents, evaluating patent portfolios, and making strategic decisions about research and development, licensing, and litigation.

Q: What tools are available for visualizing patent data? A: Tools include heat maps, citation networks, and other data visualization techniques to reveal trends and interconnections among patents.

Cited Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. USPTO. (2017). Patent Claims Research Dataset.
  3. Goldstein Patent Law. How to Do Patent Landscape Analysis.
  4. United States Patent and Trademark Office. (1994). United States Patent 5,302,400.

More… ↓

⤷  Subscribe

Details for Patent 5,302,400

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Discure Medical, Llc CHYMODIACTIN chymopapain For Injection 018663 November 10, 1982 5,302,400 2040-03-30
Discure Medical, Llc CHYMODIACTIN chymopapain For Injection 018663 August 21, 1984 5,302,400 2040-03-30
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. COTAZYM pancrelipase Capsule, Delayed Release 020580 December 09, 1996 5,302,400 2040-03-30
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 April 30, 2009 5,302,400 2040-03-30
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 June 10, 2011 5,302,400 2040-03-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.